A Breakthrough in Hemostatic Agents For Dentistry: Will They Be a Game Changer?
DOI:
https://doi.org/10.46966/msjar.v6i2.260Keywords:
Hemostasis, Local hemostatic agents, Oral surgery, BleedingAbstract
Background: Bleeding can occur during or after surgery which can be troublesome for both patient and the surgeon and if uncontrolled can lead to serious life threatening consequences. Bleeding may also compromise visibility Hemostatic agents provide control of external bleeding by enhancing the natural clotting process via various physical reactions between the agent and blood factors. Various hemostatic agents like Hemcon® (chitosan-based), TraumaDEX® (Potato starch based microparticles), QuickClot® (zeolite-based), STARSIL Hemostat, SURGISPON, CELOX BioHemostat etc, are available which have proved their effectiveness in major surgeries (Cardiothorasic, Urological, Abdominal, etc). They have been successfully introduced in the field of dental surgery recently, which is a boon in major and minor maxillofacial surgical procedures. Conclusion: The local hemostatic agents may be a great help in providing clear and bloodless field, alleviating patient anxiety, and improving patient-surgeon compliance. Newer agents are really a breakthrough in the surgical procedures, and further research is still going on for future betterment. This will be a great news for dental surgeons as bleeding is always one of the major complications in dentistry, and dentists face the problem routinely.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Dr. Nanda kishore Ghoshal
This work is licensed under a Creative Commons Attribution 4.0 International License.
In submitting the manuscript to the Medical Science Journal for Advance Research, the authors certify that:
- They are authorized by their co-authors to enter into these arrangements.
- The work described has not been formally published before, except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal.
- That it is not under consideration for publication elsewhere,
- The publication has been approved by the author(s) and by responsible authorities – tacitly or explicitly – of the institutes where the work has been carried out.
- They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
- They agree to the following license and copyright agreement.
License and Copyright Agreement
Authors who publish with Medical Science Journal for Advance Research agree to the following terms:
- Authors retain copyright and grant the Medical Science Journal for Advance Research right of first publication with the work simultaneously licensed under Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the Medical Science Journal for Advance Research published version of the work (e.g., post it to an institutional repository or edit it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
